(Q35838765)

10 August 2017

1 reference

title

Management of early inflammatory arthritis. Intervention with immunomodulatory agents: monoclonal antibody therapy (English)

1 reference

10 August 2017

1 reference

Gerd-Rüdiger Burmester

series ordinal

1

object named as

Burmester GR

1 reference

10 August 2017

G. R. Burmester

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1525846

5 October 2022

G. Horneff

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1525846

5 October 2022

F. Emmrich

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1525846

5 October 2022

language of work or name

1 reference

1 June 1992

1 reference

Bailliere's clinical rheumatology

10 August 2017

published in

1 reference

10 August 2017

volume

6

1 reference

10 August 2017

issue

2

1 reference

10 August 2017

page(s)

415-434

1 reference

Release of tumor necrosis factor, interleukin-2, and gamma-interferon in serum after injection of OKT3 monoclonal antibody in kidney transplant recipients

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980183-9

7 January 2021

Imaging rheumatoid arthritis specifically with technetium 99m CD4-specific (T-helper lymphocytes) antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980183-9

7 January 2021

Mechanisms of monoclonal antibody-facilitated tolerance induction: a possible role for the CD4 (L3T4) and CD11a (LFA-1) molecules in self-non-self discrimination

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980183-9

7 January 2021

Ia+ T cells in synovial fluid and tissues of patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980183-9

7 January 2021

Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980183-9

7 January 2021

Cytokines in chronic inflammatory arthritis. I. Failure to detect T cell lymphokines (interleukin 2 and interleukin 3) and presence of macrophage colony-stimulating factor (CSF-1) and a novel mast cell growth factor in rheumatoid synovitis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980183-9

7 January 2021

OKT3 monoclonal antibody plasma levels during therapy and the subsequent development of host antibodies to OKT3

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980183-9

7 January 2021

Long-term humoral unresponsiveness in vivo, induced by treatment with monoclonal antibody against L3T4.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980183-9

7 January 2021

Stimulation of rheumatoid synovial and blood T cells and lines by synovial fluid and interleukin-2: characterization of clones and recognition of a co-stimulatory effect

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980183-9

7 January 2021

Very late activation antigens on rheumatoid synovial fluid T lymphocytes. Association with stages of T cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980183-9

7 January 2021

Strategies of monoclonal antibody therapy that induce permanent tolerance of organ transplants

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980183-9

7 January 2021

Monoclonal anti-CD4 in arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980183-9

7 January 2021

Anti-CD4 antibody treatment of patients with rheumatoid arthritis: I. Effect on clinical course and circulating T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980183-9

7 January 2021

Lines of T Lymphocytes Induce or Vaccinate Against Autoimmune Arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980183-9

7 January 2021

Treatment of rheumatoid arthritis with an anti-CD4 monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980183-9

7 January 2021

Human anti-mouse antibody response induced by anti-CD4 monoclonal antibody therapy in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980183-9

7 January 2021

Human anti-murine immunoglobulin antibodies as disturbing factors in TSH determination

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980183-9

7 January 2021

Elevated levels of circulating tumor necrosis factor-alpha, interferon-gamma, and interleukin-2 in systemic reactions induced by anti-CD4 therapy in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980183-9

7 January 2021

Monoclonal antibody therapy. Anti-idiotypic and non-anti-idiotypic antibodies to OKT3 arising despite intense immunosuppression

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980183-9

7 January 2021

Functional and phenotypical characterization of activated T cells from intra-articular sites in inflammatory joint diseases. Possible modulation of the CD3 antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980183-9

7 January 2021

Idiotype switching of CD4-specific monoclonal antibodies can prolong the therapeutic effectiveness in spite of host anti-mouse IgG antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980183-9

7 January 2021

Lymphapheresis in rheumatoid arthritis. A randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980183-9

7 January 2021

Monoclonal antibody treatment in rheumatoid arthritis: the clinical and immunological effects of a CD7 monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980183-9

7 January 2021

Treatment of intractable rheumatoid arthritis with total lymphoid irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980183-9

7 January 2021

Beneficial effect of monoclonal antibody to interleukin 2 receptor on activated T cells in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980183-9

7 January 2021

Total lymphoid irradiation in patients with refractory rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980183-9

7 January 2021

A randomized clinical trial of OKT3 monoclonal antibody for acute rejection of cadaveric renal transplants

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980183-9

7 January 2021

Lymphocyte involvement in rheumatoid arthritis. Studies during thoracic duct drainage

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980183-9

7 January 2021

Expression of the CD2 Activation Epitope T11-3 (CD2R) on T Cells in Rheumatoid Arthritis, Juvenile Rheumatoid Arthritis, Systemic Lupus Erythematosus, Ankylosing Spondylitis, and Lyme Disease: Phenotypic and Functional Analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980183-9

7 January 2021

Treatment of rheumatoid arthritis with monoclonal CD4 antibody M-T151. Clinical results and immunopharmacologic effects in an open study, including repeated administration

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980183-9

7 January 2021

In vivo administration of anti-CD4 monoclonal antibody prolongs survival in longtailed macaques with experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980183-9

7 January 2021

Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac-transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980183-9

7 January 2021

Clinical and immunologic effects of fractionated total lymphoid irradiation in refractory rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980183-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980183-9

1 reference

7 January 2021

10.1016/S0950-3579(05)80183-9

Identifiers

DOI

1 reference

10 August 2017

1 reference